Detalhe da pesquisa
1.
MKC-Quatsomes: a stable nanovesicle platform for bio-imaging and drug-delivery applications.
Nanomedicine
; 24: 102136, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31843659
2.
Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model.
FASEB J
; 29(2): 464-76, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25359494
3.
Rational engineering of single-chain polypeptides into protein-only, BBB-targeted nanoparticles.
Nanomedicine
; 12(5): 1241-51, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26949165
4.
Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4+ colorectal cancer models.
Nanomedicine
; 12(7): 1987-1996, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27085904
5.
Structural Stabilization of Clinically Oriented Oligomeric Proteins During their Transit through Synthetic Secretory Amyloids.
Adv Sci (Weinh)
; 11(21): e2309427, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38501900
6.
Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins.
ACS Appl Mater Interfaces
; 15(33): 39167-39175, 2023 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37614001
7.
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models.
Cancers (Basel)
; 15(1)2022 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36612081
8.
Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4+ head and neck squamous cell carcinoma tumors.
Acta Pharm Sin B
; 12(5): 2578-2591, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35646535
9.
GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases.
Drug Deliv
; 29(1): 1384-1397, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35532120
10.
A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model.
Pharmaceutics
; 14(4)2022 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35456719
11.
CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma.
J Exp Clin Cancer Res
; 41(1): 49, 2022 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120582
12.
A diphtheria toxin-based nanoparticle achieves specific cytotoxic effect on CXCR4+ lymphoma cells without toxicity in immunocompromised and immunocompetent mice.
Biomed Pharmacother
; 150: 112940, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421785
13.
A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse model.
Biomaterials
; 280: 121258, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34847435
14.
Site-dependent E-cadherin cleavage and nuclear translocation in a metastatic colorectal cancer model.
Am J Pathol
; 177(4): 2067-79, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20813963
15.
Ion-dependent slow protein release from in vivo disintegrating micro-granules.
Drug Deliv
; 28(1): 2383-2391, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34747685
16.
Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing CXCR4.
J Control Release
; 335: 117-129, 2021 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34004204
17.
Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4+ Cancers.
Cancers (Basel)
; 13(12)2021 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34208189
18.
Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4+ Diffuse Large B-Cell Lymphoma Cells.
Int J Nanomedicine
; 16: 1869-1888, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33716502
19.
Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines.
Acta Biomater
; 130: 211-222, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34116228
20.
An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination.
J Hematol Oncol
; 13(1): 36, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32295630